MedPath

Influence of collagen hydrolysate on muscle mass in subjects with sarcopenia

Not Applicable
Conditions
R54
Senility
Registration Number
DRKS00006003
Lead Sponsor
niversitätsklinik Freiburg Bewegungsmedizin und Sport
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
56
Inclusion Criteria

2x 30 healthy subjects aged > 65 years with sarcopenia class I or II (1/2 SD below the normal values of a young reference pooulation in a handgrip test).
Ability to perform 1.25 Watt/kg bodyweight on a clycle ergometer without symptoms.
stable weight and nutritional behaviour.
No regular sports activity in the past (less that 1 h/week)
No contraindications regarding sports activities according to the criteriae of the ACSM
No contraindications againts supplememts.

Exclusion Criteria

contraindications regarding sports activities according to the criteriae of the ACSM, 2009.
Diagnosis of cancer within the last 5 years.
Allergy/aversion against animal protein
Inability to perform a strenght training
Arterial hypertension (RRsyst > 200 mmHg und/oder RRdiast > 105 mmHg) under resting conditions;
Insulin dependant Diabetes mellitus type II
Liver oder kidnes disease with a non-permission to ingest higher concentraions of protein.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increase in muscle mass (lean body mass) following the 3 month strength training period using DEXA-measurements (compared to the pre-training status)
Secondary Outcome Measures
NameTimeMethod
Increase in muscular power (isokinetic measurements) and <br>improvement in postural control (Posturomed) follwoing the 3 month strenght training
© Copyright 2025. All Rights Reserved by MedPath